Related Experiment Video
Updated: Aug 2, 2025

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
MiR-34 by targeting p53 induces apoptosis and DNA damage in paclitaxel-resistant human oral squamous carcinoma cells
Bardia Mortezagholi1,2, Kamyar Nasiri1,3, Emad Movahed1,4
1Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
MicroRNA-34 (miR-34) is one the most important tumor suppressor miRNAs involving in the various aspects of oral cancer. The present study aimed to evaluate the effects of miR-34 restoration in OECM-1 oral cancer resistant to paclitaxel (OECM-1/PTX) and its underlying mechanisms through p53-mediated DNA damage and apoptosis. OECM-1 and OECM-1/PTX were transfected with miR-34 mimic and inhibitor. Cellular proliferation and apoptosis were evaluated through MTT assay and flow cytometry, respectively. The mRNA and protein expression levels of p53, p-glycoprotein (P-gp), ATM, ATR, CHK1, and CHK2 were assessed through qRT-PCR and western blotting. Rhodamin123 uptake assay was used to measure the P-gp activities. P53 expression was also suppressed by sing a siRNA transfection of cells. The expression levels of miR-34 were downregulated in OECM-1/PTX. Restoration of miR-34 led to increase in cytotoxic effects of paclitaxel in cells. In addition, the expression levels and activities of P-gp were reduced following miR-34 transfection. miR-34 transfection upregulated the p53, ATM, ATR, CHK1, and CHK2 expression levels in OECM-1/PTX cells. Furthermore, cells transfected with miR-34 showed higher levels of apoptosis. miR-34 restoration reverses paclitaxel resistance in OECM-1 oral cancer. The chemosensitive effects of miR-34 is mediated through increasing DNA damage and apoptosis in a p53 depended manner.
Insights
Restoring microRNA-34 (miR-34) in oral cancer cells reversed paclitaxel resistance by increasing DNA damage and apoptosis. This effect was mediated through the p53 pathway, highlighting miR-34 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oral cancer exhibits resistance to chemotherapy, particularly paclitaxel.
- MicroRNA-34 (miR-34) functions as a tumor suppressor and is downregulated in paclitaxel-resistant oral cancer cells (OECM-1/PTX).
Purpose of the Study:
- To investigate the impact of restoring miR-34 on paclitaxel resistance in OECM-1/PTX cells.
- To elucidate the underlying mechanisms involving p53-mediated DNA damage and apoptosis.
Main Methods:
- Transfection of OECM-1/PTX cells with miR-34 mimic or inhibitor.
- Assessment of cell proliferation (MTT assay) and apoptosis (flow cytometry).
- Quantification of mRNA and protein expression (qRT-PCR, Western blotting) for p53, P-gp, ATM, ATR, CHK1, CHK2.
- Measurement of P-gp activity (Rhodamin123 uptake assay).
Main Results:
- miR-34 restoration increased paclitaxel's cytotoxic effects in OECM-1/PTX cells.
- miR-34 transfection reduced P-glycoprotein (P-gp) expression and activity.
- Restoration of miR-34 upregulated p53, ATM, ATR, CHK1, and CHK2, leading to increased apoptosis.
Conclusions:
- miR-34 restoration effectively reverses paclitaxel resistance in OECM-1 oral cancer.
- The chemosensitizing effect of miR-34 is mediated by enhanced DNA damage and apoptosis in a p53-dependent manner.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Drugs that Stabilize Microtubules
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...

